<SEC-DOCUMENT>0001213900-23-082782-index.html : 20231102 <SEC-HEADER>0001213900-23-082782.hdr.sgml : 20231102 <ACCEPTANCE-DATETIME>20231102161503 ACCESSION NUMBER: 0001213900-23-082782 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231102 DATE AS OF CHANGE: 20231102 GROUP MEMBERS: GUY LEVY GROUP MEMBERS: SOLEUS CAPITAL GROUP, LLC GROUP MEMBERS: SOLEUS CAPITAL, LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VYNE Therapeutics Inc. CENTRAL INDEX KEY: 0001566044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453757789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-90268 FILM NUMBER: 231372470 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206 N., SUITE 301 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 800-775-7936 MAIL ADDRESS: STREET 1: 685 ROUTE 202/206 N., SUITE 301 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics Inc. DATE OF NAME CHANGE: 20180201 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics, Inc. DATE OF NAME CHANGE: 20170728 FORMER COMPANY: FORMER CONFORMED NAME: Tigercat Pharma, Inc. DATE OF NAME CHANGE: 20130104 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Soleus Capital Master Fund, L.P. CENTRAL INDEX KEY: 0001812275 IRS NUMBER: 981413657 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 104 FIELD POINT ROAD STREET 2: 2ND FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 4752083111 MAIL ADDRESS: STREET 1: 104 FIELD POINT ROAD STREET 2: 2ND FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G <SEQUENCE>1 <FILENAME>ea187561-13gsoleus_vyne.htm <DESCRIPTION>SCHEDULE 13G <TEXT> Document 1 - file: ea187561-13gsoleus_vyne.htm
</DOCUMENT> </SEC-DOCUMENT>